# Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI

> **NCT04695106** · PHASE4 · UNKNOWN · sponsor: **Medical University of Gdansk** · enrollment: 2230 (estimated)

## Conditions studied

- Atrial Fibrillation
- Antithrombotic Therapy
- Acute Coronary Syndrome
- Percutaneous Coronary Interventions

## Interventions

- **DRUG:** Ticagrelor
- **DRUG:** Dabigatran Etexilate
- **DRUG:** Aspirin
- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT04695106
- **Lead sponsor:** Medical University of Gdansk
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-25
- **Primary completion:** 2024-03-01
- **Final completion:** 2026-03-31
- **Target enrollment:** 2230 (ESTIMATED)
- **Last updated:** 2021-11-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04695106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04695106, "Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04695106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*